TGFB1 and chronic myelogenous leukemia, BCR-ABL1 positive: However, in CML, EVs containing TGFβ1 did not induce an immunosuppressive environment; instead, they promoted proliferation and survival of leukemic cells in an autocrine manner, both in vitro and in vivo.